Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
TRUPANION, INC. (TRUP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TRUP at 44.4/100 on a 32-signal composite quality model, placing it at rank #1,918 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (30.0) and balance sheet strength (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 35.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), TRUPANION, INC. reports quarterly revenue of $392.9M, net income of $6.8M, an operating margin of 1.6%. TRUP trades on the Nasdaq exchange and files with the SEC under CIK 1371285. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRUP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TRUPANION, INC. directly from SEC EDGAR.
AI Quality Score
44.4/100
AI Rank
#1,918
Revenue
$392.9M
Net Income
$6.8M
Free Cash Flow
$19.2M
Operating Margin
1.6%
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $1.4B | $19.4M | 1.0% |
| FY 2024 | 10-K | $1.3B | $-9.6M | -0.7% |
| FY 2023 | 10-K | $1.1B | $-44.7M | -3.7% |
| FY 2022 | 10-K | $905.2M | $-44.7M | -4.8% |
| FY 2021 | 10-K | $699.0M | $-35.5M | -5.0% |
| FY 2020 | 10-K | $502.0M | — | -1.0% |
13F Pro Quality Score
Rank #1,918 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk